These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9264515

  • 1. Chelation therapy for peripheral arterial occlusive disease: a systematic review.
    Ernst E.
    Circulation; 1997 Aug 05; 96(3):1031-3. PubMed ID: 9264515
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Therapy of arterial occlusive diseases. The effect of bencyclan in trained patients with peripheral arterial occlusive disease (Double-blind study)].
    Battke K, Buchwalsky R, Barmeyer J, Hoffmann G, Reindell H.
    Fortschr Med; 1978 Jul 20; 96(26-27):1381-6. PubMed ID: 669532
    [No Abstract] [Full Text] [Related]

  • 4. [Walk training and drug therapy in peripheral arterial occlusive disease. A randomized, prospective, placebo-controlled double-blind study].
    Kiesewetter H, Blume J, Jung F, Gerhards M, Leipnitz G.
    Dtsch Med Wochenschr; 1987 May 29; 112(22):873-8. PubMed ID: 3556133
    [Abstract] [Full Text] [Related]

  • 5. [Hemodilution in peripheral arterial occlusive disease. Placebo controlled randomized double-blind study with hydroxyethyl starch or dextran].
    Ernst E, Kollar L, Matrai A.
    Acta Med Austriaca; 1991 May 29; 18 Suppl 1():27-9. PubMed ID: 1719730
    [Abstract] [Full Text] [Related]

  • 6. [Hypervolemic hemodilution with bloodletting in patients with peripheral arterial occlusive disease].
    Kiesewetter H, Blume HJ, Jung F, Bach R, Spitzer S, Leipnitz G, Schieffer H, Bette L, Wenzel E.
    Vasa Suppl; 1988 May 29; 26():107-12. PubMed ID: 2462283
    [No Abstract] [Full Text] [Related]

  • 7. Peripheral arterial disease.
    Anand S, Creager M.
    Clin Evid; 2002 Jun 29; (7):79-90. PubMed ID: 12230639
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Design and method of clinical trials of drugs used in the therapy of stable peripheral arterial occlusive disease].
    Wink K.
    Arzneimittelforschung; 2006 Jun 29; 56(1):52-7. PubMed ID: 16478006
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Hemodilution in patients with multiple morbidity and peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Bach R, Birk A, Schieffer H, Wenzel E.
    Schweiz Med Wochenschr; 1989 Dec 23; 119(51):1862-7. PubMed ID: 2481883
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Iso- and hypervolemic hemodilution with hydroxyethyl starch (HES 200/.05 10%) in patients with II b peripheral arterial occlusive disease].
    Kiesewetter H, Blume J, Jung F, Spitzer S, Gerhards M, Waldhausen P, Wenzel E.
    Wien Med Wochenschr; 1989 Sep 15; 139(17):396-401. PubMed ID: 2480029
    [Abstract] [Full Text] [Related]

  • 16. [Comments on guidelines for therapeutic studies in Fontaine's stage II-IV peripheral arterial occlusive disease].
    Heidrich H, Trampisch HJ, Roehmel J.
    Vasa; 1996 Sep 15; 25(1):73-5. PubMed ID: 8851269
    [No Abstract] [Full Text] [Related]

  • 17. Oxygen transport in peripheral arterial occlusive disease: effects of calf blood dialysate.
    Rossano C, Weiner M, Haigis E.
    Angiology; 1993 Jun 15; 44(6):471-6. PubMed ID: 8503513
    [Abstract] [Full Text] [Related]

  • 18. Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.
    Edvinsson LI, Edvinsson ML, Angus Deveber G.
    Int Angiol; 2003 Jun 15; 22(2):141-7. PubMed ID: 12865879
    [Abstract] [Full Text] [Related]

  • 19. Midterm results of the COLD study.
    Forbes TL.
    J Vasc Surg; 2009 Aug 15; 50(2):452. PubMed ID: 19631887
    [No Abstract] [Full Text] [Related]

  • 20. Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients.
    Wilson SE.
    Ann Vasc Surg; 2010 May 15; 24(4):498-502. PubMed ID: 20036508
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.